Product
Estradiol + Norethindrone acetate
1 clinical trial
2 indications
Indication
Heavy menstrual bleedingIndication
Uterine FibroidClinical trial
LIBERTY EXTENSION: An International Phase 3 Open-Label, Single-Arm, Long-Term Efficacy and Safety Extension Study to Evaluate Relugolix Co-Administered With Low-Dose Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine FibroidsStatus: Completed, Estimated PCD: 2020-01-21